CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model

Cutaneous T‐cell lymphoma (CTCL) encompasses two main subtypes: mycosis fungoides and Sezary syndrome. Global response rates for the systemic treatment of mycosis fungoides and Sezary syndrome are approximately 30%, and none of these treatments are thought to be curative. C–C chemokine receptor type...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaohui, Ma, Jihong, Zhang, Huiping, Ramakrishna, Rashmi, Mintzlaff, Danielle, Mathes, David W., Pomfret, Elizabeth A., Lucia, M. Scott, Gao, Dexiang, Haverkos, Bradley M., Wang, Zhirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315799/
https://www.ncbi.nlm.nih.gov/pubmed/37157185
http://dx.doi.org/10.1002/2211-5463.13625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315799/
https://www.ncbi.nlm.nih.gov/pubmed/37157185
http://dx.doi.org/10.1002/2211-5463.13625

Ejemplares similares